Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

RSV in Older Adults: Immunology and Vaccine Development

Learn from a leading expert about RSV immunology, the economic burden of RSV, and the current status of the most promising vaccines in development for older adults.
Dexter James Wiseman, MD
Released: May 5, 2022

In this episode, Dexter James Wiseman, MD, discusses immunology and RSV vaccine development for older adults, including:

  • Need for a vaccine
  • Economic burden of RSV
  • Reasons for poor outcomes in older adults
  • Investigational vaccine

Information on this Educational Activity

Faculty

Dexter James Wiseman, MD

Clinical Research Fellow
NHLI
Imperial College
Physician
Respiratory Medicine
Royal Brompton Hospital
London, United Kingdom

Dexter James Wiseman, MD, has disclosed that he has received consulting fees from GlaxoSmithKline and Janssen.

Program Medium

This program has been made available online.

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Janssen Therapeutics, Division of Janssen Products, LP

Related Content

Prof. Sharon R. Lewin: expert insights on remdesivir for nonhospitalized adult and pediatric patients with COVID-19, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Prof. Sharon R. Lewin discusses ivermectin and the evolution of monoclonal antibody treatments during omicron, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Megan Coffee, MD, PhD, discusses the newest data on SARS-CoV-2 diagnostics from CROI 2022 and elsewhere, from Clinical Care Options (CCO)

Megan Coffee, MD, PhD (DPhil) Released: June 2, 2022

Frequently asked questions and answers: evolving data on COVID-19 epidemiology, prevention, and treatment, from Clinical Care Options (CCO)

Arthur Kim, MD Sharon R. Lewin, AO, FRACP, PhD, FAHMS Renslow Sherer, MD Released: June 1, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings